High <i>IL2RA</i>/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core‐binding factor
Takahiro Aoki(Saitama Children's Medical Center), Daisuke Tomizawa(National Center For Child Health and Development), Keizo Horibe(National Hospital Organization), Shota Kato(The University of Tokyo), Kenichi Yoshida(Kyoto University), Takashi Taga(Erasmus MC), Norio Shiba(Gunma University), Akira Shimada(Tohoku University), Akio Tawa(Erasmus MC), Seishi Ogawa(Keio University), Yuka Iijima‐Yamashita(Nagoya Medical Center), Shin‐ichi Tsujimoto(Yokohama City University), Genki Yamato(Gunma University), Souichi Adachi(Kyoto University), Tomohiko Taki(Kyorin University), Shotaro Iwamoto(Mie University), Yasuhide Hayashi(Gunma Children's Medical Center), Yusuke Hara(Kitasato University)
Cited by 7
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
|Journal of Clinical Oncology|2015|383